⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1992500 | 0.72 | — | — | |
| SCHEMBL15061158 | 0.70 | — | — | |
| SCHEMBL1990839 | 0.67 | — | — | |
| SCHEMBL30367005 | 0.67 | — | — | |
| SCHEMBL2051931 | 0.65 | — | — | |
| SCHEMBL2495482 | 0.64 | — | — | |
| SCHEMBL610481 | 0.64 | — | — | |
| SCHEMBL1993707 | 0.64 | — | — | |
| SCHEMBL15661694 | 0.61 | — | — | |
| SCHEMBL722777 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127073-B | Imidazopyrimidines as EED inhibitors and use thereof | 密歇根大学董事会 | 2024-05-31 | — | — | CN | disclosed |
| CN-117897382-A | Nitrogen-containing tricyclic compounds and pharmaceutical uses thereof | 日本烟草产业株式会社 | 2024-04-16 | — | — | CN | disclosed |
| CN-117813098-A | Methods of treating diseases or conditions | 苏州亚盛药业有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117794930-A | KRAS inhibitors | 苏州亚盛药业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-116916963-A | Multivalent ligand clusters with diamine scaffolds for targeted delivery of therapeutic agents | 上海舶望制药有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-112300130-B | Tricyclic compounds as BCR-ABL inhibitors | 苏州亚盛药业有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-113087700-B | Spirocyclic tetrahydroquinazolines | 苏州亚盛药业有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115380033-A | SETD2 inhibitors and related methods and uses, including combination therapies | EPIZYME股份有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-115212311-A | Pharmaceutical composition and application thereof | 苏州亚盛药业有限公司 | 2022-10-21 | — | — | CN | disclosed |